In Prague, the company introduced the HAB80-60KA/KB automated ultra-low temperature storage system. Designed for biorepositories holding between 50,000 and 200,000 samples, the unit utilizes a modular architecture that allows facilities to scale their storage capacity on demand. The system integrates AI-driven monitoring to maintain consistent -80°C environments, while Professor Marco Agostini of the Università degli Studi di Padova utilized the booth to demonstrate academic-industry integration for biobanking research.

Simultaneously in Tokyo, the focus shifted to space-constrained laboratory environments. The company launched the DWL368BPST ultra-low temperature freezer, featuring a slim 670mm width tailored for local Japanese facilities. This model improves upon standard industry performance, offering 26% lower energy consumption and a 45% faster temperature recovery rate compared to conventional units. By prioritizing localized R&D, Haier Biomedical is moving away from simple product export toward an integrated ecosystem model, partnering directly with hospitals and research institutions to embed their technology into daily scientific workflows.